394P Apatinib plus etoposide capsules as third-line or further-line treatment for extensive stage small cell lung cancer patients: A multicenter, single arm, phase II clinical trial
Keyword(s):
Keyword(s):
2014 ◽
Vol 37
(4)
◽
pp. 176-180
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 21
(1)
◽
pp. 1-12
◽
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):